Shanghai, China Shanghai Nuokai Investment Management is the famous VC, which was founded in 2014. The main department of described VC is located in the Shanghai. The fund was located in Asia if to be more exact in China.
Among the most popular portfolio startups of the fund, we may highlight Medtrum. For fund there is a match between the location of its establishment and the land of its numerous investments - China. We can highlight the next thriving fund investment areas, such as Medical Device, Medical. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 5 participants. The meaningful sponsors for the fund in investment in the same round are ZJ Innopark (Zhangjiang Hi-Tech Park), Sequoia Capital China, Bank of China Group Investment.
The top activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars.
| Fund Name | Location |
| Beijing Chengchuang Lihe Angel Investment Company | Beijing, Beijing, China |
| Cazador Acquisition Corporation Ltd | Bulgaria, Grad Sofiya, Sofia |
| Feng Hua Chang Sheng | Beijing, China, Tongzhou |
| GHS Ventures | - |
| Guangxi Wuzhou Pharmaceutical Group | - |
| Hoshino Resorts | Japan, Nagano, Nagano Prefecture |
| J Ventures | New York, New York, United States |
| Jintanglang | China, Guangxi, Jiangsu |
| Kaihuo Shangwu | China, Hunan, Longhui |
| Mac Fund | Seoul, Seoul-t'ukpyolsi, South Korea |
| Miele Venture | - |
| NorgesInvestor | Norway, Oslo |
| OGCI Climate Investments | England, London, United Kingdom |
| Ojas Venture Partners | Bangalore, India, Karnataka |
| Regents of the University of California | California, Oakland, United States |
| Rogue Capital | California, San Francisco, United States |
| Shanghai Haoshuo Investment | - |
| Still Capital Partners | - |
| Zhongzhi Hulian | China, Futian, Guangdong |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Etern | 31 Aug 2021 | Shanghai, Shanghai, China | |||
Medtrum | $29M | 25 Dec 2018 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Etern | 31 Aug 2021 | Shanghai, Shanghai, China | |||
Medtrum | $29M | 25 Dec 2018 | Shanghai, China |
